1. Home
  2. HCAI vs NVNO Comparison

HCAI vs NVNO Comparison

Compare HCAI & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCAI

Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$2.17

Market Cap

7.7M

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

N/A

Current Price

$11.12

Market Cap

6.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HCAI
NVNO
Founded
2004
1987
Country
China
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
6.8M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
HCAI
NVNO
Price
$2.17
$11.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.7K
15.3K
Earning Date
05-23-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$31,243.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$140.00
P/E Ratio
$63.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$0.30
52 Week High
$25.99
$13.44

Technical Indicators

Market Signals
Indicator
HCAI
NVNO
Relative Strength Index (RSI) 21.63 53.08
Support Level $0.24 $9.96
Resistance Level $5.16 $11.40
Average True Range (ATR) 0.40 0.73
MACD -0.09 0.03
Stochastic Oscillator 6.69 62.91

Price Performance

Historical Comparison
HCAI
NVNO

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: